NYSE - Delayed Quote USD
Cencora, Inc. (COR)
At close: 4:00 PM EDT
After hours: 5:10 PM EDT
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 15 | 10 | 18 | 18 |
| Avg. Estimate | 3.21 | 3.51 | 13.63 | 14.74 |
| Low Estimate | 3.15 | 3.43 | 13.58 | 13.6 |
| High Estimate | 3.25 | 3.65 | 13.67 | 15.19 |
| Year Ago EPS | 2.86 | 3.28 | 11.99 | 13.63 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 12 | 7 | 15 | 15 |
| Avg. Estimate | 77.62B | 77.09B | 292.61B | 310.97B |
| Low Estimate | 76.56B | 75.83B | 291.47B | 292.51B |
| High Estimate | 78.55B | 79.85B | 293.45B | 317.18B |
| Year Ago Sales | 68.92B | -- | 262.17B | 292.61B |
| Sales Growth (year/est) | 12.60% | -- | 11.60% | 6.30% |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | 2.8 | 2.89 | 3.69 | 3.22 |
| EPS Actual | 2.86 | 3.28 | 3.8 | 3.34 |
| Difference | 0.06 | 0.39 | 0.11 | 0.12 |
| Surprise % | 2.10% | 13.50% | 3.00% | 3.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 3.21 | 3.51 | 13.63 | 14.74 |
| 7 Days Ago | 3.2 | 3.51 | 13.63 | 14.81 |
| 30 Days Ago | 3.2 | 3.51 | 13.62 | 14.83 |
| 60 Days Ago | 3.18 | 3.51 | 13.6 | 14.88 |
| 90 Days Ago | 3.19 | 3.49 | 13.46 | 14.73 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 1 | 2 | -- |
| Up Last 30 Days | 3 | 1 | 3 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | 1 | -- | 3 |
Growth Estimates
| CURRENCY IN USD | COR | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 12.20% | -- | -- | 4.10% |
| Next Qtr. | 7.00% | -- | -- | 7.60% |
| Current Year | 13.70% | -- | -- | 2.50% |
| Next Year | 8.10% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 10.10% | -- | -- | 11.89% |
| Past 5 Years (per annum) | 14.29% | -- | -- | -- |
Upgrades & Downgrades
| Maintains | JP Morgan: Overweight to Overweight | 8/21/2024 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 8/1/2024 |
| Maintains | Baird: Outperform to Outperform | 8/1/2024 |
| Maintains | Baird: Outperform to Outperform | 7/9/2024 |
| Maintains | Leerink Partners: Outperform to Outperform | 6/27/2024 |
| Maintains | Baird: Outperform to Outperform | 5/2/2024 |
Related Tickers
CAH Cardinal Health, Inc.
111.93
-0.55%
MCK McKesson Corporation
508.72
-0.43%
HSIC Henry Schein, Inc.
71.67
-0.11%
PDCO Patterson Companies, Inc.
21.10
+1.05%
OMI Owens & Minor, Inc.
14.06
+0.21%
ZYXI Zynex, Inc.
7.95
+0.76%
MCK.SG McKesson Corp
468.30
-0.43%
NEU.WA NEUCA S.A.
812.00
-3.22%
UPR.IR Uniphar plc
2.4200
+1.26%
AHG Akso Health Group
0.9401
-5.99%